Initial CT Findings and CO-RADS Stage in COVID-19
Comparison of Initial CT Findings and CO-RADS Stage in COVID-19 Patients With PCR, Inflammation and Coagulation Parameters in Diagnostic and Prognostic Perspectives
1 other identifier
observational
895
1 country
2
Brief Summary
This study aims to determine whether patients with different real-time reverse transcriptase-polymerase chain reaction (PCR), chest computed tomography (CT) and laboratory findings have different clinical outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2021
Shorter than P25 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 4, 2021
CompletedStudy Start
First participant enrolled
March 4, 2021
CompletedFirst Posted
Study publicly available on registry
March 9, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 6, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
May 6, 2021
CompletedJune 9, 2021
June 1, 2021
2 months
March 4, 2021
June 4, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
mortality
mortality during hospitalization and within 14 days after hospitalization
up to 30 days
Secondary Outcomes (2)
need for intensive care
up to 30 days
need for intenvasive mechanical ventilation
up to 30 days
Study Arms (1)
COVID-19 patients in hospital
All patients aged 18 years and over, positive for SARS-CoV-2 PCR test and / or Covid-19 treatment with signs of Covid-19 disease on CT
Eligibility Criteria
Patients who are diagnosed with Covid-19 in a two tertier hospital in Turkey
You may qualify if:
- Aged 18 years and over,
- Having SARS-CoV-2 RT-PCR test and chest CT examinations performed at the time of application or within 24 hours after admission
- RT-PCR positivity in nasopharyngeal swabs sample, and/or the presence of clinical and laboratory findings of SARS-CoV-2 infection and/or the presence of COVID-19-compatible radiological findings in chest CT, and being diagnosed with COVID-19
You may not qualify if:
- Patients with negative SARS-CoV-2 PCR test, pneumonia on CT but not given Covid-19 treatment by not considering Covid-19 by their doctor will not be included.
- Patients whose data are not available
- Patients with poor CT image quality
- Patients who were transferred to another hospital
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Sultan Abdülhamid Han Training and Research Hospital
Istanbul, 34660, Turkey (Türkiye)
Sultan Abdülhamid Han Training and Research Hospital
Istanbul, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Elif Yıldırım Ayaz, M.D.
Sultan Abdülhamid Han Training and Rsearch Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 4, 2021
First Posted
March 9, 2021
Study Start
March 4, 2021
Primary Completion
May 6, 2021
Study Completion
May 6, 2021
Last Updated
June 9, 2021
Record last verified: 2021-06